Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir
Author(s) -
Luigia Rossi,
Palmarisa Franchetti,
Francesca Pierigè,
Loredana Cappellacci,
Sonja Serafini,
E Balestra,
Carlo Federico Perno,
Mario Grifantini,
R Caliò,
Mauro Magnani
Publication year - 2007
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkm011
Subject(s) - lamivudine , phagocytosis , in vivo , macrophage , in vitro , viral replication , virus , pharmacokinetics , biology , pharmacology , virology , chemistry , microbiology and biotechnology , biochemistry , hepatitis b virus
(i) To generate a new heterodinucleotide (3TCpPMPA) comprising the drugs lamivudine and tenofovir which have been shown to act synergistically and (ii) to protect macrophages from 'de novo' HIV-1-infection through its administration.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom